Alyeska Investment Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$1.4M	–	515
2019 Q3	$1.4M	Buy	+50,000	New	+$1.4M	0.02%	284
2017 Q3	–	Sell	-35,000	Closed	-$780K	–	550
2017 Q2	$780K	Buy	+35,000	New	+$780K	0.01%	399